These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 37816413)

  • 1. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
    Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
    Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis.
    Woo TE; Sibley CD
    J Am Acad Dermatol; 2020 Jan; 82(1):222-228. PubMed ID: 31499149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nutrition, food allergies, and gut dysbiosis in immune-mediated inflammatory skin disease: a narrative review.
    Bourkas AN; Lara-Corrales I
    Curr Opin Pediatr; 2023 Aug; 35(4):452-459. PubMed ID: 37335275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.
    Mahmud MR; Akter S; Tamanna SK; Mazumder L; Esti IZ; Banerjee S; Akter S; Hasan MR; Acharjee M; Hossain MS; Pirttilä AM
    Gut Microbes; 2022; 14(1):2096995. PubMed ID: 35866234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Microbiome: Composition and Role in Inflammatory Skin Diseases.
    Balato A; Cacciapuoti S; Di Caprio R; Marasca C; Masarà A; Raimondo A; Fabbrocini G
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):1-18. PubMed ID: 30302512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of IL-36: an emerging therapeutic target for inflammatory dermatoses.
    Hwang J; Rick J; Hsiao J; Shi VY
    J Dermatolog Treat; 2022 Sep; 33(6):2711-2722. PubMed ID: 35470744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel.
    Langan EA; Recke A; Bokor-Billmann T; Billmann F; Kahle BK; Zillikens D
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
    Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
    Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin and gut microbiota dysbiosis in autoimmune and inflammatory skin diseases.
    Šuler Baglama Š; Trčko K
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Sep; 31(3):105-109. PubMed ID: 36149040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.
    Luck ME; Tao J; Lake EP
    Am J Clin Dermatol; 2022 Nov; 23(6):841-852. PubMed ID: 36116091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are Heading.
    Świerczewska Z; Lewandowski M; Surowiecka A; Barańska-Rybak W
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived stress in four inflammatory skin diseases: an analysis of data taken from 7273 adult subjects with acne, atopic dermatitis, psoriasis or hidradenitis suppurativa.
    Misery L; Chesnais M; Merhand S; Aubert R; Bru MF; Legrand C; Raynal H; Taieb C; Richard MA
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e623-e626. PubMed ID: 35181931
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptomic Analysis of Hidradenitis Suppurativa: A Unique Molecular Signature with Broad Immune Activation.
    Ben Abdallah H; Bregnhøj A; Iversen L; Johansen C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin Barrier Function and the Microbiome.
    Lee HJ; Kim M
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What's New in Dermatological Therapy?].
    Bachelez H
    Ann Dermatol Venereol; 2015 Dec; 142 Suppl 3():S49-54. PubMed ID: 26792414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic dermatitis: Pathophysiology, microbiota, and metabolome - A comprehensive review.
    Mohammad S; Karim MR; Iqbal S; Lee JH; Mathiyalagan R; Kim YJ; Yang DU; Yang DC
    Microbiol Res; 2024 Apr; 281():127595. PubMed ID: 38218095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach.
    Iannone M; Janowska A; Panduri S; Morganti R; Davini G; Romanelli M; Dini V
    Exp Dermatol; 2022 Jun; 31(6):956-961. PubMed ID: 35285091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
    Yim RM; Singh I; Armstrong AW
    Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular Skin Disorders, Inflammatory Bowel Disease, and the Microbiome: A Systematic Review.
    Fleshner L; Roster K; Farabi B; Hirani R; Tepper K; Pitchumoni CS; Safai B; Marmon S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Practical Guide to Using Biologics in Pediatric Dermatology.
    George A; Lansang RP; Lansang P; Gooderham M
    J Cutan Med Surg; 2024; 28(1):59-67. PubMed ID: 38229411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.